TRACON Pharmaceuticals, Inc. (TCON) DCF Valuation

Valoración de DCF de Tracon Pharmaceuticals, Inc. (TCON)

US | Healthcare | Biotechnology | NASDAQ
TRACON Pharmaceuticals, Inc. (TCON) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

TRACON Pharmaceuticals, Inc. (TCON) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Descubra el verdadero potencial de Tracon Pharmaceuticals, Inc. (TCON) con nuestra calculadora DCF avanzada! Ajuste los supuestos clave, explore varios escenarios y evalúe cómo las fluctuaciones afectan la valoración de Tracon Pharmaceuticals, Inc. (TCON), todo dentro de una plantilla de Excel integral.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .3 .0 12.0 9.0 6.8 5.1 3.8 2.9
Revenue Growth, % 0 0 0 -100 0 -25 -25 -25 -25 -25
EBITDA -22.3 -16.2 -28.3 -27.9 -6.9 2.6 1.9 1.5 1.1 .8
EBITDA, % 100 100 -8188.73 100 -57.15 28.57 28.57 28.57 28.57 28.57
Depreciation .0 .0 .0 .0 .0 5.5 4.1 3.1 2.3 1.7
Depreciation, % 100 100 4.05 100 0.11623 60.83 60.83 60.83 60.83 60.83
EBIT -22.3 -16.2 -28.3 -27.9 -6.9 2.6 1.9 1.5 1.1 .8
EBIT, % 100 100 -8192.77 100 -57.27 28.55 28.55 28.55 28.55 28.55
Total Cash 16.4 36.1 24.1 17.4 8.6 8.5 6.4 4.8 3.6 2.7
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 0 100 0
Inventories .0 .0 .0 .0 .0 5.4 4.1 3.0 2.3 1.7
Inventories, % 100 100 0 100 0 60 60 60 60 60
Accounts Payable 2.4 1.7 4.9 3.9 2.5 7.6 5.7 4.3 3.2 2.4
Accounts Payable, % 100 100 1428.61 100 21.12 84.22 84.22 84.22 84.22 84.22
Capital Expenditure .0 .0 .0 .0 .0 -.3 -.2 -.1 -.1 -.1
Capital Expenditure, % 100 100 -13.87 100 0 -2.77 -2.77 -2.77 -2.77 -2.77
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -22.3 -16.8 -28.4 -28.1 -6.9 2.6 1.9 1.5 1.1 .8
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -19.9 -17.4 -25.2 -29.1 -8.3 2.0 6.7 5.0 3.8 2.8
WACC, % 715.64 716.15 716.15 716.15 716.15 716.05 716.05 716.05 716.05 716.05
PV UFCF
SUM PV UFCF .4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 3
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt -8
Equity Value 8
Diluted Shares Outstanding, MM 2
Equity Value Per Share 4.86

What You Will Get

  • Real TCON Financial Data: Pre-filled with TRACON Pharmaceuticals' historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See TRACON Pharmaceuticals' intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Real-Life TCON Data: Pre-filled with TRACON Pharmaceuticals’ historical financials and future projections.
  • Fully Customizable Inputs: Modify revenue growth, margins, WACC, tax rates, and capital expenditures to suit your analysis.
  • Dynamic Valuation Model: Automatically updates Net Present Value (NPV) and intrinsic value based on your customized inputs.
  • Scenario Testing: Develop multiple forecasting scenarios to evaluate various valuation outcomes.
  • User-Friendly Design: Intuitive and structured, catering to both professionals and newcomers.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered TRACON Pharmaceuticals data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for TRACON Pharmaceuticals’ intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for TRACON Pharmaceuticals, Inc. (TCON)?

  • All-in-One Solution: Combines DCF, WACC, and financial ratio analyses specifically tailored for TCON.
  • Flexible Inputs: Modify yellow-highlighted fields to explore different financial scenarios.
  • In-Depth Analysis: Automatically computes TRACON's intrinsic value and Net Present Value.
  • Preloaded Information: Historical and projected data provide a solid foundation for analysis.
  • Expert-Level Tool: Perfect for financial analysts, investors, and business advisors focusing on TCON.

Who Should Use This Product?

  • Investors: Assess TRACON Pharmaceuticals, Inc.’s (TCON) fair value to inform investment strategies.
  • CFOs: Utilize an advanced DCF model for accurate financial reporting and analysis.
  • Consultants: Easily customize the template for client valuation reports related to TRACON Pharmaceuticals.
  • Entrepreneurs: Learn from the financial modeling practices of leading biotech firms.
  • Educators: Employ this tool to illustrate valuation techniques in academic settings.

What the Template Contains

  • Historical Data: Includes TRACON Pharmaceuticals’ past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate TRACON Pharmaceuticals’ intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of TRACON Pharmaceuticals’ financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.